Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Al-Mondhiry

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
The American Journal of Medicine|January 1, 1976
Association of a chromosomal abnormality with lymphocytes having both T and B markers in a patient with lymphoproliferative diseaseF P Siegal, R Voss, H Al-Mondhiry, et al.
Blood|November 1, 1982
Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone)S Kempin, B J Lee, H T Thaler, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
The American Journal of Medicine|January 1, 1976
Association of a chromosomal abnormality with lymphocytes having both T and B markers in a patient with lymphoproliferative diseaseF P Siegal, R Voss, H Al-Mondhiry, et al.
Blood|November 1, 1982
Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone)S Kempin, B J Lee, H T Thaler, et al.
Pageof 5